Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The use of zenocutuzumab for NRG1 fusion–positive tumors [Interview]
    Miscellaneous

    Schram, A.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of regorafenib in recurrent/metastatic adenoid cystic carcinoma
    Journal Article

    Desilets, A.; Vos, J. L.; Katabi, N.; Kuo, F.; Nadeem, Z.; Linxweiler, M.; Ostrovnaya, I.; Baxi, S.; Dunn, L. A.; Sherman, E. J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Precision oncology: 2024 in review
    Review

    Repetto, M.; Fernandez, N.; Drilon, A.; Chakravarty, D.
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Differences in ancestry and presence of gastric precursor lesions in individuals with young- and average-onset gastric cancer
    Journal Article

    Magahis, P. T.; Cornet, N.; Tang, L.; Arora, K.; Hingorani, N.; King, S.; Markowitz, A. J.; Schattner, M.; Shimada, S.; Maron, S. B.; more...
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
    Journal Article

    Hamidi, H.; Senbabaoglu, Y.; Beig, N.; Roels, J.; Manuel, C.; Guan, X.; Koeppen, H.; Assaf, Z. J.; Nabet, B. Y.; Waddell, A.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Oral self-management of palbociclib using mobile technology: Findings from a nurse-led randomized controlled trial
    Journal Article

    Mazzella-Ebstein, A. M.; Barton-Burke, M.; Anthony, V.; White, C.; Zhang, Z.; Smith, A.; Robson, M.
    Asia-Pacific Journal of Oncology Nursing (2024)

    Fulltext@MSK | Save
  • The promises and potential pitfalls of pharmacokinetic model–based dosing in cellular therapy
    Correspondence

    Scordo, M.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Model-based dosing for better survival after transplantation
    Editorial

    Boelens, J. J.; Scordo, M.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Lung cancer research and treatment: Global perspectives and strategic calls to action
    Review

    Meyer, M. L.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. C.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Characterization of recurrent gene amplifications in copy numerhigh endometrial cancers
    Meeting Abstract

    Roy, A.; Dagher, C.; Abu-Rustum, N. R.; Aghajanian, C.; Mueller, J. J.; Weigelt, B.; Chui, M. H.; Boroujeni, A. M.
    Virchows Archiv (2024)

    Fulltext@MSK | Save